Medicare Expands Coverage Of Continuous Glucose Monitors

US Medicare has issued a final rule broadening coverage of continuous glucose monitors, including those integrated with Medtronic insulin pumps. The rule classifies adjunctive monitors, which treat diabetes, as durable medical equipment under the Medicare Part B benefit.

FINGERPRICK CGM
A DIABETES PATIENT USES A FINGERSTICK TO MEASURE BLOOD GLUCOSE LEVELS • Source: Alamy

The US Centers for Medicare & Medicaid Services (CMS) has issued a final rule that increases treatment options for diabetes patients with government plans.

The Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) rule expands Medicare coverage of continuous glucose monitors (CGMs) by classifying...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Durable Medical Equipment

FDA Publishes Updated ‘Roadmap’ For Advancing Women’s Health

 

The US FDA’s Office of Women’s Health provides a research roadmap to address health concerns specific to women. The FDA recently updated the roadmap, outlining areas in which further research is needed.

Latest Philips Recall Linked To Death, Injuries

 

Philips has issued a recall of various Trilogy ventilators due to safety issues that may affect their ability to properly function. The US FDA has designated the recall class I, its most serious.

X-ray Regulations Detailed In New FDA Guidance

 

The US FDA has published final guidance to provide clarification for industry and agency staff on federal regulations of diagnostic X-ray equipment.

Device Shortages A Matter Of National Security, Califf Says

 

During an online seminar hosted by the Alliance for a Stronger FDA, Commissioner Robert Califf discussed key issues facing the agency, including supply chains, device shortages, and the risk of another pandemic.

More from Device Area

SpotitEarly Sets Up US HQ, Launches Trials For Dog- And AI-Powered Early Cancer Detection Test

 
• By 

Among early cancer screening tests, SpotitEarly stands out by combining dogs’ superior sense of smell with machine learning. SpotitEarly plans two US clinical trials for breast and lung cancer aiming to seek FDA clearance, but needs more funding to support clinical development and commercialization.

Additional Death And Injuries Added To 2024 Philips Ventilator Recall

 

Philips Respironics has updated instructions for use for three ventilators that were included in a May 2024 recall. The company also added three potential injuries and one death to the original number.

Ultromics Wins $55M, The Key To Success: Diagnosing Diseases With Available Treatment

 

Ultromics has secured $55m in Series C funding to advance its AI tool, EchoGo, which detects undiagnosed heart failure. The company's focus on diseases with available treatments resonated with investors.